Skip to main content

Table 2 Original diagnosis and revised diagnosis after expert revision and immunohistochemistry

From: Distinct pattern of lymphoid neoplasms characterizations according to the WHO classification (2016) and prevalence of associated Epstein–Barr virus infection in Nigeria population

ORIGINAL DIAGNOSIS

 

BL

n = 2

CLL

n = 5

AITL

n = 2

DLBCL

n = 12

HL/HD

n = 6

PCM

n = 1

Reactive

n = 15

Carcinoma

n = 1

FL

n = 1

NK lymphoma

n = 1

LPL

n = 1

MALT

n = 2

NHL

n = 53

REVISED DIAGONSIS

CLL

n = 23

1

4

1

1

16

HL

n = 17

1

1

5

2

8

DLBCL

n = 14

1

4

1

1

7

BL

n = 5

2

1

2

SMZL

n = 2

2

ENMZL

n = 1

1

B-LBL

n = 1

1

AITL

n = 1

1

FL

n = 1

1

LPL

n = 1

1

Sarcoma

n = 4

4

Metastasis

n = 6

1

1

1

3

CD

n = 2

1

1

RDD

n = 2

2

Reactive

n = 22

1

10

1

10

  1. AITL Angioimmunoblastic T-cell lymphoma, BL Burkitt lymphoma, B-LBL B-lymphoblastic leukaemia/lymphoma, CD Castleman disease, CLL chronic lymphocytic leukemia, DLBCL diffuse large B-cell lymphomas, ENMZL extranodal marginal zone lymphoma, FL follicular lymphoma, HL Hodgkin lymphoma, HD Hodgkin disease, LPL lymphoplasmacytic lymphoma, NHL non-Hodgkin lymphomas, PCM plasmacytoma, RDD Rosai-Dorfman disease, SMZL splenic marginal zone lymphoma